<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03407521</url>
  </required_header>
  <id_info>
    <org_study_id>R02 MH12345</org_study_id>
    <nct_id>NCT03407521</nct_id>
  </id_info>
  <brief_title>Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion</brief_title>
  <official_title>Measuring Response of Adding Isosorbide Mononitrate to Misoprostol in Induction of Second Trimester Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      the investigators aimed to study the efficacy and safety of nitric oxide donors when combined
      with prostaglandins in induction of second trimester abortion expecting that both drugs when
      used together will be of greater efficiency and associated with less side effects.

      the study included 60 women with gestational age between 13weeks+0day and 26weeks+6days
      indicated for pregnancy termination due to maternal or fetal cause.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the study aimed to compare the effect of isosorbid mononitrate when combined with misoprostol
      and misoprostol when used alone in second trimester abortion, expecting that both drugs when
      used together will be more effective and associated with fewer side effects.

      In this study 60 women were enrolled, divided into two groups. The first group (group I), 30
      women received misoprostol and isosorbid mononitrate.

      The second group (group II), 30 women received misoprostol and placebo. The primary aim of
      the study was the occurrence of complete abortion in the first 24 hours.

      The study concluded that the combination of isosorbid mononitrate with misoprostol is more
      effective in second trimester abortion than misoprostol with placebo, but is associated with
      more side effects mainly headache.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 12, 2017</start_date>
  <completion_date type="Actual">December 15, 2017</completion_date>
  <primary_completion_date type="Actual">October 22, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>induction abortion interval</measure>
    <time_frame>24 hours</time_frame>
    <description>time needed to induce abortion in second trimester abortion</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Second Trimester Abortion</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>misoprostol tab 200mcg 2 tab at first then one every 4 hours with isosorbide mononitrate 20mg once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>misoprostol tab 200mcg 2 tab at first then one every 4 hours with placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>induction of abortion using misoprostol</description>
    <arm_group_label>study group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>isosorbide mononitrate</intervention_name>
    <description>isosorbide mononitrate</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 16 -40 years

          -  Missed abortion

          -  Singelton pregnancy

          -  Gestationl age between 13 and 26 weeks of pregnancy

          -  Normal uterus and cevix on clinical examination

          -  Cervix is not dilatated

          -  No uterine activity and vaginal bleeding

          -  Written and informed consent by the patient

          -  Unscarred uterus

        Exclusion Criteria:

          -  Presence of uterine contraction or bleeding

          -  Evidences suggesting of onset of spontaneous abortion as Previous trial to induce
             abortion

          -  Multifetal pregnancy

          -  Suspicion of septic abortion

          -  History of cervical surgery or manipulation

          -  Uterine anomaly

          -  IUD in situ

          -  Associtaed hemorrhagic disorder

          -  History of adverse effects to vaginally adminstered medication

          -  Inability to insert vaginal medication high in vagina
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mohamed ab elsenity, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>11566</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Jain JK, Mishell DR Jr. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obstet Gynecol. 1996 Jul;175(1):173-7.</citation>
    <PMID>8694046</PMID>
  </results_reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2018</study_first_submitted>
  <study_first_submitted_qc>January 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mohamed abd elfatah elsenity</investigator_full_name>
    <investigator_title>lecturer MD</investigator_title>
  </responsible_party>
  <keyword>second trimester abortion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
    <mesh_term>Isosorbide</mesh_term>
    <mesh_term>Isosorbide-5-mononitrate</mesh_term>
    <mesh_term>Isosorbide Dinitrate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>publish in scientific journals</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

